Global Heart Failure Treatment Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Heart Failure Treatment Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Drug Treatment
- 1.4.3 Surgical Treatment
- 1.5 Market by Application
- 1.5.1 Global Heart Failure Treatment Market Share by Application (2019-2025)
- 1.5.2 Acute Heart Failure
- 1.5.3 Chronic Heart Failure
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Heart Failure Treatment Market Size
- 2.2 Heart Failure Treatment Growth Trends by Regions
- 2.2.1 Heart Failure Treatment Market Size by Regions (2019-2025)
- 2.2.2 Heart Failure Treatment Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Heart Failure Treatment Market Size by by Players
- 3.1.1 Global Heart Failure Treatment Revenue by by Players (2014-2019)
- 3.1.2 Global Heart Failure Treatment Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Heart Failure Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Heart Failure Treatment Key Players Head office and Area Served
- 3.3 Key Players Heart Failure Treatment Product/Solution/Service
- 3.4 Date of Enter into Heart Failure Treatment Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Heart Failure Treatment Market Size by Type (2014-2019)
- 4.2 Global Heart Failure Treatment Market Size by Application (2014-2019)
5 North America
- 5.1 North America Heart Failure Treatment Market Size (2014-2019)
- 5.2 Heart Failure Treatment Key Players in North America
- 5.3 North America Heart Failure Treatment Market Size by Type
- 5.4 North America Heart Failure Treatment Market Size by Application
6 Europe
- 6.1 Europe Heart Failure Treatment Market Size (2014-2019)
- 6.2 Heart Failure Treatment Key Players in Europe
- 6.3 Europe Heart Failure Treatment Market Size by Type
- 6.4 Europe Heart Failure Treatment Market Size by Application
7 China
- 7.1 China Heart Failure Treatment Market Size (2014-2019)
- 7.2 Heart Failure Treatment Key Players in China
- 7.3 China Heart Failure Treatment Market Size by Type
- 7.4 China Heart Failure Treatment Market Size by Application
8 Japan
- 8.1 Japan Heart Failure Treatment Market Size (2014-2019)
- 8.2 Heart Failure Treatment Key Players in Japan
- 8.3 Japan Heart Failure Treatment Market Size by Type
- 8.4 Japan Heart Failure Treatment Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Heart Failure Treatment Market Size (2014-2019)
- 9.2 Heart Failure Treatment Key Players in Southeast Asia
- 9.3 Southeast Asia Heart Failure Treatment Market Size by Type
- 9.4 Southeast Asia Heart Failure Treatment Market Size by Application
10 India
- 10.1 India Heart Failure Treatment Market Size (2014-2019)
- 10.2 Heart Failure Treatment Key Players in India
- 10.3 India Heart Failure Treatment Market Size by Type
- 10.4 India Heart Failure Treatment Market Size by Application
11 Central & South America
- 11.1 Central & South America Heart Failure Treatment Market Size (2014-2019)
- 11.2 Heart Failure Treatment Key Players in Central & South America
- 11.3 Central & South America Heart Failure Treatment Market Size by Type
- 11.4 Central & South America Heart Failure Treatment Market Size by Application
12 International Players Profiles
- 12.1 Pfizer
- 12.1.1 Pfizer Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Heart Failure Treatment Introduction
- 12.1.4 Pfizer Revenue in Heart Failure Treatment Business (2014-2019))
- 12.1.5 Pfizer Recent Development
- 12.2 Novartis
- 12.2.1 Novartis Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Heart Failure Treatment Introduction
- 12.2.4 Novartis Revenue in Heart Failure Treatment Business (2014-2019)
- 12.2.5 Novartis Recent Development
- 12.3 Merck
- 12.3.1 Merck Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Heart Failure Treatment Introduction
- 12.3.4 Merck Revenue in Heart Failure Treatment Business (2014-2019)
- 12.3.5 Merck Recent Development
- 12.4 Sanofi
- 12.4.1 Sanofi Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Heart Failure Treatment Introduction
- 12.4.4 Sanofi Revenue in Heart Failure Treatment Business (2014-2019)
- 12.4.5 Sanofi Recent Development
- 12.5 Johnson & Johnson
- 12.5.1 Johnson & Johnson Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Heart Failure Treatment Introduction
- 12.5.4 Johnson & Johnson Revenue in Heart Failure Treatment Business (2014-2019)
- 12.5.5 Johnson & Johnson Recent Development
- 12.6 AstraZeneca
- 12.6.1 AstraZeneca Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Heart Failure Treatment Introduction
- 12.6.4 AstraZeneca Revenue in Heart Failure Treatment Business (2014-2019)
- 12.6.5 AstraZeneca Recent Development
- 12.7 GlaxoSmithKline
- 12.7.1 GlaxoSmithKline Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Heart Failure Treatment Introduction
- 12.7.4 GlaxoSmithKline Revenue in Heart Failure Treatment Business (2014-2019)
- 12.7.5 GlaxoSmithKline Recent Development
- 12.8 Amgen
- 12.8.1 Amgen Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Heart Failure Treatment Introduction
- 12.8.4 Amgen Revenue in Heart Failure Treatment Business (2014-2019)
- 12.8.5 Amgen Recent Development
- 12.9 Bayer
- 12.9.1 Bayer Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Heart Failure Treatment Introduction
- 12.9.4 Bayer Revenue in Heart Failure Treatment Business (2014-2019)
- 12.9.5 Bayer Recent Development
- 12.10 BMS
- 12.10.1 BMS Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Heart Failure Treatment Introduction
- 12.10.4 BMS Revenue in Heart Failure Treatment Business (2014-2019)
- 12.10.5 BMS Recent Development
- 12.11 Cardiorentis
- 12.12 Cytokinetics
- 12.13 Ono Pharmaceuticals
- 12.14 Mylan
- 12.15 NCPC
- 12.16 Xinhua Group
- 12.17 Xudong Haipu Pharmaceutical
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
This report focuses on the global Heart Failure Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Heart Failure Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Pfizer
Novartis
Merck
Sanofi
Johnson & Johnson
AstraZeneca
GlaxoSmithKline
Amgen
Bayer
BMS
Cardiorentis
Cytokinetics
Ono Pharmaceuticals
Mylan
NCPC
Xinhua Group
Xudong Haipu Pharmaceutical
Market segment by Type, the product can be split into
Drug Treatment
Surgical Treatment
Market segment by Application, split into
Acute Heart Failure
Chronic Heart Failure
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Heart Failure Treatment status, future forecast, growth opportunity, key market and key players.
To present the Heart Failure Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Heart Failure Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.